Loading clinical trials...
Loading clinical trials...
This study is designed to investigate the efficacy and safety of QBX258 in subjects with moderate to severe asthma.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT06979323 · Asthma
NCT06664619 · Asthma
NCT07431021 · Asthma Acute, Respiratory
NCT07383896 · Asthma, COPD
NCT07356310 · Breathing, Lung Function Decreased, and more
Novartis Investigative Site
Anaheim, California
Novartis Investigative Site
Riverside, California
Novartis Investigative Site
Rolling Hills Estates, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions